Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haplo-HSCT vs MUD-HSCT in Elderly Patients with Hematological Malignancies
NCT02623309Phase 3Completed
- Sponsor
- Institut Paoli-Calmettes
- Start
- Feb 2016
- Primary completion
- Feb 2021
- Modality
- Small Molecules, Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of allogeneic hematopoietic stem cells in hematologic neoplasms, sponsored by Institut Paoli-Calmettes. Started Feb 2016; status: completed.
02
Drugs
allogeneic hematopoietic stem cells
03
Conditions
hematologic neoplasms
Beyond the preview
Go deeper on NCT02623309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02623309.